EVLO Company Profile and Key Details

Q: Who are the executives of EVLO?

Ms. Julie CarreteroChief People OfficerDr. Balkrishan Gill Ph.D.Pres, Chief Executive Officer & DirectorDr. Chun Zhang Ph.D.Chief Technical Operations & Quality OfficerMs. Marella ThorellChief Financial Officer, Senior Vice President, Principal Financial Officer & TreasurerMs. Jessica CotroneVice President & Head of CommunicationsMr. Stephen J. CarriereVice President & Chief Accounting OfficerDr. Stu AbelGlobal Head of Regulatory Affairs & EU Head of Clinical Devel.Dr. Mark Bodmer Ph.D.Chief Scientific Officer and Pres of R&DMs. Leslie Wardwell-Scott Ph.D.Vice President and Head of Corporation Devel. & Strategic IntegrationDr. Duncan McHale M.D., MBBS, Ph.D.Chief Medical OfficerDr. Balkrishnan Gill Ph.D.Pres, Chief Executive Officer & DirectorDr. Andrea Itano Ph.D.Head of ResearchMr. Douglas MaslinSenior Director & Immunology Clinical LeadDr. Jonathan B. Zung Ph.D.Chief Devel. Officer

NASDAQ : EVLO

Evelo Biosciences

$0.00

At Close 4:00 PM

59.44

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Evelo Biosciences, Inc. (EVLO) stock remained unchanged at $0.00 a share on OTC. The stock opened at $0.00, fluctuating between $0.00 to $0.00 during the session.

Stock Snapshot

0.0001

Prev. Close

1.9K

Market Cap

0.0001

Day Low

N/A

P/E Ratio

-9.25

EPS (TTM)

-4.26

Cash Flow per Share

Open

18.98M

Number of Shares

0.0005

Day High

99.55%

Free Float in %

-1.54

Book Value

133

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 02, 2026	0.00	0.00	0.00	0.00	233
Aug 27, 2026	0.00	0.00	0.00	0.00	151
Aug 17, 2026	0.00	0.00	0.00	0.00	328
Aug 07, 2026	0.00	0.00	0.00	0.00	520
Jul 30, 2026	0.00	0.00	0.00	0.00	881
Jul 17, 2026	0.00	0.00	0.00	0.00	377
Jul 08, 2026	0.00	0.00	0.00	0.00	1.05K
Jul 07, 2026	0.00	0.00	0.00	0.00	250
Jun 18, 2026	0.00	0.00	0.00	0.00	6.17K
Jun 15, 2026	0.00	0.00	0.00	0.00	1.5K
Jun 12, 2026	0.00	0.00	0.00	0.00	400
Jun 09, 2026	0.00	0.00	0.00	0.00	6.7K
May 07, 2026	0.00	0.00	0.00	0.00	333
May 06, 2026	0.00	0.00	0.00	0.00	163
Apr 28, 2026	0.00	0.00	0.00	0.00	531
Apr 22, 2026	0.00	0.00	0.00	0.00	16.3K
Apr 21, 2026	0.00	0.00	0.00	0.00	437
Apr 16, 2026	0.00	0.00	0.00	0.00	400
Apr 09, 2026	0.00	0.00	0.00	0.00	2.81K
Apr 02, 2026	0.00	0.00	0.00	0.00	678

Contact Details

Cambridge, MA 02139

United States

https://www.evelobio.com 617 577 0300

About Company

Evelo Biosciences, Inc. is a biotechnology firm dedicated to identifying and advancing oral biologic therapies for various inflammatory conditions and oncological diseases. Its pipeline includes EDP1815, a whole-microbe compound designed to address inflammatory ailments, currently undergoing Phase 2 clinical trials for conditions such as psoriasis and atopic dermatitis, and also being evaluated for the hyperinflammatory reaction associated with COVID-19. Additional developments include EDP1867, an inactivated oral biologic in Phase 1b for inflammatory diseases; EDP2939, an investigational oral biologic based on extracellular vesicles targeting inflammatory diseases; and EDP1908, a drug candidate focused on cancer. Established in 2014, Evelo Biosciences, Inc. operates from its headquarters in Cambridge, Massachusetts.

Stock Peers

LZAGF

-5-0.92%

Lonza Group AG$541.00 GNMSF

Genmab A/S$268.61 CMXHF

CSL Limited$192.00 CSLLY

0.75+0.79%

CSL Limited$95.35 UCBJY

-0.06-0.08%

UCB SA$73.15 LZAGY

-0.33-0.61%

Lonza Group AG$53.87 PHMMF

4.3+16.01%

Pharma Mar, S.A.$31.15 BVNKF

Bavarian Nordic A/S$21.20 GRTX

1.53+9.80%

Galera Therapeutics, Inc.$17.15 NURPF

Neuren Pharmaceuticals Limited$14.00

Frequently Asked Questions

What is the current Evelo Biosciences, Inc. (EVLO) stock price?

Evelo Biosciences, Inc. (OTC: EVLO) stock price is $0.00 in the last trading session. During the trading session, EVLO stock reached the peak price of $0.00 while $0.00 was the lowest point it dropped to. The percentage change in EVLO stock occurred in the recent session was 0% while the dollar amount for the price change in EVLO stock was $0.00.

EVLO's industry and sector of operation?

The OTC listed EVLO is part of Biotechnology industry that operates in the broader Healthcare sector. Evelo Biosciences, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of EVLO?

Ms. Julie Carretero
Chief People Officer
Dr. Balkrishan Gill Ph.D.
Pres, Chief Executive Officer & Director
Dr. Chun Zhang Ph.D.
Chief Technical Operations & Quality Officer
Ms. Marella Thorell
Chief Financial Officer, Senior Vice President, Principal Financial Officer & Treasurer
Ms. Jessica Cotrone
Vice President & Head of Communications
Mr. Stephen J. Carriere
Vice President & Chief Accounting Officer
Dr. Stu Abel
Global Head of Regulatory Affairs & EU Head of Clinical Devel.
Dr. Mark Bodmer Ph.D.
Chief Scientific Officer and Pres of R&D
Ms. Leslie Wardwell-Scott Ph.D.
Vice President and Head of Corporation Devel. & Strategic Integration
Dr. Duncan McHale M.D., MBBS, Ph.D.
Chief Medical Officer
Dr. Balkrishnan Gill Ph.D.
Pres, Chief Executive Officer & Director
Dr. Andrea Itano Ph.D.
Head of Research
Mr. Douglas Maslin
Senior Director & Immunology Clinical Lead
Dr. Jonathan B. Zung Ph.D.
Chief Devel. Officer

How EVLO did perform over past 52-week?

EVLO's closing price is 0% higher than its 52-week low of $0.00 where as its distance from 52-week high of $0.00 is -80%.

How many employees does EVLO have?

Number of EVLO employees currently stands at 66.

Link for EVLO official website?

Official Website of EVLO is: https://www.evelobio.com

How do I contact EVLO?

EVLO could be contacted at phone 617 577 0300 and can also be accessed through its website. EVLO operates from 600/700, One Kendall Square, Cambridge, MA 02139, United States.

How many shares of EVLO are traded daily?

EVLO stock volume for the day was 133 shares. The average number of EVLO shares traded daily for last 3 months was 89.

What is the market cap of EVLO currently?

The market value of EVLO currently stands at $1.90K with its latest stock price at $0.00 and 18.98M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	66
Beta	1.31
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	66
Beta	1.31
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

EVLO Company Profile and Key Details

Evelo Biosciences

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Shareholding & Insider Activity

Company Overview

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Valuation Metrics

Key Takeaways

Price Forecast & Outlook